32 related articles for article (PubMed ID: 33836336)
1. Predicting the status of lymphovascular space invasion using quantitative parameters from synthetic MRI in cervical squamous cell carcinoma without lymphatic metastasis.
Guo L; Zhang R; Xu Y; Wu W; Zheng Q; Li J; Wang J; Niu J
Front Oncol; 2024; 14():1304793. PubMed ID: 38380361
[TBL] [Abstract][Full Text] [Related]
2. Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images.
Downey K; Riches SF; Morgan VA; Giles SL; Attygalle AD; Ind TE; Barton DP; Shepherd JH; deSouza NM
AJR Am J Roentgenol; 2013 Feb; 200(2):314-20. PubMed ID: 23345352
[TBL] [Abstract][Full Text] [Related]
3. T1 mapping as a quantitative imaging biomarker for diagnosing cervical cancer: a comparison with diffusion kurtosis imaging.
Zhang Z; Liu J; Zhang Y; Qu F; Grimm R; Cheng J; Wang W; Zhu J; Li S
BMC Med Imaging; 2024 Jan; 24(1):16. PubMed ID: 38200447
[TBL] [Abstract][Full Text] [Related]
4. Preoperative prediction of lymphovascular space invasion in endometrioid adenocarcinoma: an MRI-based radiomics nomogram with consideration of the peritumoral region.
Yan B; Jia Y; Li Z; Ding C; Lu J; Liu J; Zhang Y
Acta Radiol; 2023 Sep; 64(9):2636-2645. PubMed ID: 37312525
[TBL] [Abstract][Full Text] [Related]
5. Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasion.
Yue XN; He XY; Wu JJ; Fan W; Zhang HJ; Wang CW
Clin Radiol; 2023 Aug; 78(8):e574-e581. PubMed ID: 37183140
[TBL] [Abstract][Full Text] [Related]
6. Radiomic features of cervical cancer on T2-and diffusion-weighted MRI: Prognostic value in low-volume tumors suitable for trachelectomy.
Wormald BW; Doran SJ; Ind TE; D'Arcy J; Petts J; deSouza NM
Gynecol Oncol; 2020 Jan; 156(1):107-114. PubMed ID: 31685232
[TBL] [Abstract][Full Text] [Related]
7. Can the ADC Value Be Used as an Imaging "Biopsy" in Endometrial Cancer?
Petrila O; Nistor I; Romedea NS; Negru D; Scripcariu V
Diagnostics (Basel); 2024 Feb; 14(3):. PubMed ID: 38337842
[TBL] [Abstract][Full Text] [Related]
8. 3D MR elastography-based stiffness as a marker for predicting tumor grade and subtype in cervical cancer.
Xiao Y; Chen W; Long X; Li M; Zhang L; Liu C; Deng Y; Li C; He B; Chen J; Wang J
Magn Reson Imaging; 2024 Jun; 109():173-179. PubMed ID: 38484948
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic performance of ADC value for tumor grade, deep myometrial invasion and lymphovascular space invasion in endometrial cancer: a meta-analysis.
Yan BC; Xiao ML; Li Y; Wei Qiang J
Acta Radiol; 2019 May; ():284185119841988. PubMed ID: 31042066
[TBL] [Abstract][Full Text] [Related]
10. Can the combination of DWI and T2WI radiomics improve the diagnostic efficiency of cervical squamous cell carcinoma?
Wang S; Jiang T; Hu X; Hu H; Zhou X; Wei Y; Mao X; Zhao Z
Magn Reson Imaging; 2022 Oct; 92():197-202. PubMed ID: 35842193
[TBL] [Abstract][Full Text] [Related]
11. Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma.
Liu B; Xu Y; Hu B; Song X; Lin S; Wang J; Wang L; Chu T; Peng T; Xu M; Ding W; Cao C; Wu P; Li L
Aging (Albany NY); 2024 Jan; 16(1):568-592. PubMed ID: 38206304
[TBL] [Abstract][Full Text] [Related]
12. Radiomic Analysis of Quantitative T2 Mapping and Conventional MRI in Predicting Histologic Grade of Bladder Cancer.
Ye L; Wang Y; Xiang W; Yao J; Liu J; Song B
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762841
[TBL] [Abstract][Full Text] [Related]
13. T1 and T2 mapping for identifying malignant lymph nodes in head and neck squamous cell carcinoma.
Qu J; Pan B; Su T; Chen Y; Zhang T; Chen X; Zhu X; Xu Z; Wang T; Zhu J; Zhang Z; Feng F; Jin Z
Cancer Imaging; 2023 Dec; 23(1):125. PubMed ID: 38105217
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of accelerated T2 mapping for the preoperative assessment of endometrial carcinoma.
Zhang Z; Liu J; Wang W; Zhang Y; Qu F; Hilbert T; Kober T; Cheng J; Li S; Zhu J
Front Oncol; 2023; 13():1117148. PubMed ID: 37564932
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for the recurrence of cervical cancer using MR-based T1 mapping: A pilot study.
Liu J; Li S; Cao Q; Zhang Y; Nickel MD; Wu Y; Zhu J; Cheng J
Front Oncol; 2023; 13():1133709. PubMed ID: 37007135
[TBL] [Abstract][Full Text] [Related]
16. Study of T2 mapping in quantifying and discriminating uterine lesions under different magnetic field strengths: 1.5 T vs. 3.0 T.
Zhu L; Lu W; Wang F; Wang Y; Wu PY; Zhou J; Liu H
BMC Med Imaging; 2023 Jan; 23(1):1. PubMed ID: 36600192
[TBL] [Abstract][Full Text] [Related]
17. Application of synthetic magnetic resonance imaging and DWI for evaluation of prognostic factors in cervical carcinoma: a prospective preliminary study.
Zhang W; Lu N; He H; Liu H; Zhu F; Ma L; Luo Y; Qian L; Meng T; Xie C
Br J Radiol; 2023 Jan; 96(1141):20220596. PubMed ID: 36341699
[TBL] [Abstract][Full Text] [Related]
18. The feasibility of a radial turbo-spin-echo T2 mapping for preoperative prediction of the histological grade and lymphovascular space invasion of cervical squamous cell carcinoma.
Li S; Zhang Z; Liu J; Zhang F; Yang M; Lu H; Zhang Y; Han F; Cheng J; Zhu J
Eur J Radiol; 2021 Jun; 139():109684. PubMed ID: 33836336
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
